Navigation Links
Cytopia Appoints Study Chairman for JAK2 Clinical Trial
Date:7/29/2008

MELBOURNE, Australia, July 29 /PRNewswire-FirstCall/ -- Cytopia Limited (ASX: CYT) has appointed Dr. Ayalew Tefferi, Professor of Medicine and Hematology at the Mayo Clinic College of Medicine, as Clinical Study Chair for the company's Phase I/II study in patients with myelofibrosis.

Dr. Tefferi is a world-renowned expert in the treatment of myeloproliferative disorders (MPDs) and has authored over 500 research publications and given many hundreds of invited lectures in haematology. He also serves on the editorial boards of a number of leading haematology journals.

Myelofibrosis patients suffer a bone marrow disorder in which the marrow is replaced by fibrous scar tissue. Patients will be treated in this study with Cytopia's novel orally available compound CYT387. This drug inhibits the mutant JAK2 enzyme to specifically treat haematological malignancies, including myelofibrosis.

Many of these particular diseases can lead to life threatening conditions such as leukemia. There are currently no effective long term treatments for these conditions.

"Cytopia is delighted that a clinician of Dr. Tefferi's standing has agreed to chair our Phase I/II program," said Mr. Andrew Macdonald, CEO. "Dr. Tefferi and our other clinical investigators will study and document the clinical benefits of using this highly promising JAK2 inhibitor to treat these blood disorders."

Following the completion of very encouraging in-vivo studies at Oregon Health and Science University early in the year, CYT387 has been undergoing rigorous IND-enabling toxicology studies in recent months. It is anticipated that an Investigational New Drug application will be lodged with the US Food and Drug Administration by the end of the year to support studies in Australia and the United States.

About JAK2

The discovery of a specific single activating mutation in the JAK2 enzyme in MPDs in 2005 has focused attention on developing a therapy for these diseas
'/>"/>

SOURCE Cytopia Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders
2. Cytopia Announces Novel Anti-Cancer Drug Development Collaboration
3. Release of Cytopia Abstract for CYT997 Oral Presentation at American Society of Clinical Oncology
4. Quark Pharmaceuticals Appoints New Chief Medical Officer
5. West Pharmaceutical Services, Inc. Appoints New Director
6. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
7. Curemark Appoints Preeminent Pediatrics Gastroenterologist
8. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
9. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... BD (Becton, Dickinson a...pletion of its acquisition of HandyLab, Inc., an A... manufactures molecular diagnostic assays and auto...ab announced an exclusive agreement for BD to deve...yLab Jaguar(TM) platform, the first fully integrat...
(Date:11/19/2009)...ewswire/ -- Warner Chilcott plc (Nasdaq: WCRX ) t...nced secondary offering of 20,000,000 of its ordin...share. The selling shareholders include funds aff...anking, J.P. Morgan Partners (advised by CCMP Capi...er institutional investors and members of the Comp...
(Date:11/19/2009)...RNewswire-FirstCall/ -- In a series of new initiat...orporation (Nasdaq: HSKA ) ("Heska" or the "Compa...roved website. The upgraded site is the result of...g to align the site with the company,s new brand i...p://www.newscom.com/cgi-bin/prnh/20000622/HESKALOG...
Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Progressive Radio Network Takes on Controversial H1N1 Vaccine Debate 60026 1Progressive Radio Network Takes on Controversial H1N1 Vaccine Debate 60026 2Progressive Radio Network Takes on Controversial H1N1 Vaccine Debate 60026 3MyEMRchoice com develops EMR Power Rankings for Selection of Electronic Medical Records 60023 1MyEMRchoice com develops EMR Power Rankings for Selection of Electronic Medical Records 60023 2NAMI Applauds NPR Story Highlighting Mental Health on Campus 60020 1NAMI Applauds NPR Story Highlighting Mental Health on Campus 60020 2
...AL DEVICE INNOVATIONS AND SOUTHERN CALIFORNIA,S TE...y 12 More than 200 members of Southern California...l DeviceFest on May 7th, featuring panel discussio...ing options, as well as showcasing the latest in m... Fairmont Hotel was sponsored by BIOCOM, Southern ...
...he Hooters of Orange Park is hosting a car wash to...wash begins at 10 AM at the Hooters of Orange Park... reached at (904) 215-5858. , , All donations fr...2 Million breast cancer research grant. Every Hoo...rough various charitable efforts in the name of th...
Other Medicine Technology:BIOCOM's 4th Annual DeviceFest Honors Companies 2BIOCOM's 4th Annual DeviceFest Honors Companies 3
(Date:11/21/2009)...ask whether there is a secret to ,alcohol rehab su... London, UK (PRWEB) November 21, 2009 -- Li... the adult UK population drinking enough alcohol t...r disease*, it is hardly a surprise that many are ...and residential centres for help. However, for som...
(Date:11/20/2009)...ewswire-USNewswire/ -- The United States Conferenc...ential changes its health reform bill in order to ...conscience protection on abortion, protect access ...rovisions for adequate affordability. ,, The bi...ous disappointment" that creates new and unaccepta...
(Date:11/20/2009)...USNewswire/ -- The American Dental Association (AD...on (FDA) to establish appropriate classifications ...rn about the safety of whitening products that are...ional consultation or examination by a dentist, th...lly based tooth whitening or bleaching agents can ...
(Date:11/20/2009)...-USNewswire/ -- The following is a statement by Ch...th Care Association: ,, "The Nevada Health Care...ority Leader Harry Reid for his leadership in taki...tecting every Nevada seniors, ongoing access to qu...th and viability of our state,s vital frontline wo...
(Date:11/20/2009)...en with chronic kidney disease often fail to detec... increasing a child,s risk for serious heart prob...ldren,s Center and other institutions. A report of...rican Society of Nephrology. , Researchers com...regular doctor visits to readings obtained via a s...
Breaking Medicine News(10 mins):Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:High blood pressure easy to miss in children with kidney disease 2
...s, Inc.,announced today that it had completed succ...rations of the efficacy of its new "traceless",ant...any applications. The,in vivo and some of the in v...l synthesis and can only be obtained from,sources ...
...ania,Trauma Systems Foundation which is the accred... released data to the Pennsylvania Legislative Bud...f motorcyclists involved in,crashes since the repe...al Center supports the need for the,Pennsylvania l...
...verage for Wheelchairs,Oxygen, and Other Home Medi...19 Nearly three out of,four (74 percent) American...tion to the problem of rapidly increasing Medicare...s conducted by,Harris Interactive found that stron...
...alth care,professionals at Alabama Fertility Speci... Assisted Reproductive Technology (ART) insurance ...ostly, but effective procedures,like in vitro fert...essionals became concerned when they discovered Ho...
...ring has designed and created a new product specif..., Burnsville Minn. (PRWEB)..., fabricator and installer of http://www.gerbig.c...is an integrated wall mounted pre-filter. The pre...
...egal authority to knowing the steps to take and wh...lle, Ill. (Vocus) August 19, 2008 -- Each year mil...e impairment that makes it difficult or impossible...pport the financial well-being and health of indiv...
Other Medicine News:Health News:Afid Therapeutics Inc.'s New Anticoagulant Heparin Replacement Passes in Vivo Test 2Health News:Republican and Democratic Voters View Home Care as a Solution to Rising Medicare Spending, Harris Survey Finds 2Health News:Republican and Democratic Voters View Home Care as a Solution to Rising Medicare Spending, Harris Survey Finds 3Health News:Honda Criticized for Discriminatory Insurance Practices 2Health News:Honda Criticized for Discriminatory Insurance Practices 3Health News:Allsup Outlines Five Critical Issues for Caregivers Preparing to Take on Financial and Healthcare Responsibilities 2Health News:Allsup Outlines Five Critical Issues for Caregivers Preparing to Take on Financial and Healthcare Responsibilities 3Health News:Allsup Outlines Five Critical Issues for Caregivers Preparing to Take on Financial and Healthcare Responsibilities 4Health News:Allsup Outlines Five Critical Issues for Caregivers Preparing to Take on Financial and Healthcare Responsibilities 5Health News:Allsup Outlines Five Critical Issues for Caregivers Preparing to Take on Financial and Healthcare Responsibilities 6Health News:Allsup Outlines Five Critical Issues for Caregivers Preparing to Take on Financial and Healthcare Responsibilities 7Health News:Allsup Outlines Five Critical Issues for Caregivers Preparing to Take on Financial and Healthcare Responsibilities 8
Universal Biomedical Amplifier (UBA-4204)
...e professionals to measure corneal thickness faste...ogy. The PACHETT 3 uses the exact enhanced corneal... pachymeters used exclusively by the OHTS investig...measuring and storing up to 25 measurements bilate...
...viscoelastic solution of highly purified sodium hy...cular weight (greater than 1 million daltons) sodi...In the limit of zero shear rate, the viscosity is ...is approximately 320 milliosmols. Sodium hyalurona...
AT20R Visual Function Tester
Medicine Products: